Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs in hematological malignancies
Year: 2017
Type: article
Abstract: The indisputable role of epigenetics in cancer and the fact that epigenetic alterations can be reversed have favoured development of epigenetic drugs. In this study, we design and synthesize potent novel, selective and reversible chemical probes that simultaneously inhibit the G9a and DNMTs methyltransferase activity. In vitro treatment of haematological neoplasia (acute myeloid leukaemia-AML, acute lymphoblastic leukaemia-ALL and diffuse large B-cell lymphoma-DLBCL) with the lead compound CM-272, inhibits cell proliferation and promotes apoptosis, inducing interferon-stimulated genes and immunogenic cell death. CM-272 significantly prolongs survival of AML, ALL and DLBCL xenogeneic models. Our results represent the discovery of first-in-class dual inhibitors of G9a/DNMTs and establish this chemical series as a promising therapeutic tool for unmet needs in haematological tumours.
Source: Nature Communications
DOI: 10.1038/ncomms15424
Authors: Edurne San José-Enériz, Xabier Agirre, Obdulia Rabal, Amaia Vilas-Zornoza, Juan A. Sanchez-Arias, Estibaliz Miranda, Ana Ugarte, Sergio Roa, Bruno Paiva, Ander Estella-Hermoso de Mendoza, Rosa María Alvarez, Noelia Casares, Victor Segura, José I. Martín-Subero, François-Xavier Ogi, Pierre Soule, Clara M. Santiveri, Ramón Campos-Olivas, Giancarlo Castellano, Maite Garcia Fernandez de Barrena, Juan Roberto Rodriguez-Madoz, Maria José García-Barchino, Juan Jose Lasarte, Matias A Avila, Jose Angel Martinez-Climent, Julen Oyarzabal, Felipe Prosper
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Keywords: G9a, DNA methyltransferases, hypomethylating agents, histone methyltransferase inhibitors, dual inhibitors, epigenetic drugs, hematologic malignancies, acute myeloid leukemia, acute lymphoblastic leukemia, diffuse large B-cell lymphoma, immunogenic cell death, interferon-stimulated genes, apoptosis, xenograft survival
Open Access status: gold
Estimated APC paid: $6,990
Awards: G1201740324, G1988565201, Papel de la (hidroxi)metilación del DNA en la regulación de los RNAs largos no codificantes en el Mieloma Múltiple, Inhibición de la actividad metiltransferasa de G9a mediante moléculas pequeñas como estrategia terapéutica en tumores hematológicos, G4853731464, Role of DNA methylation in the regulation of lincRNAs in Hematological Malignancies
OpenAlex ID: W2618258562
